No change to FY 2023 outlook but some EUV orders for H2 2024 remain to be booked. With an order backlog of ~$39 billion, ASML will ride out this semi storm relatively unscathed compared to their peers
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
Unlock all research summaries
Follow top, independent analysts
Receive personalised alerts and emails
Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.